{
    "2018-01-10": [
        [
            {
                "time": "2023-10-01",
                "original_text": "医药生物行业深度研究报告：处方外流正当时院外市场济蓝海",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "处方外流",
                        "院外市场"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-02",
                "original_text": "中生制药获里昂续予优于大市 现仍跌近2%",
                "features": {
                    "keywords": [
                        "中生制药",
                        "里昂",
                        "优于大市",
                        "下跌"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-03",
                "original_text": "乙型流感严重吗 哪些抗流感概念股明显受益",
                "features": {
                    "keywords": [
                        "乙型流感",
                        "抗流感",
                        "概念股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "又双叒叕到流感高发季这些“抗流感”龙头来势汹汹",
                "features": {
                    "keywords": [
                        "流感高发季",
                        "抗流感",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "8330万元定增被股东大会否决，上市公司控股新三板海欣医药失败！",
                "features": {
                    "keywords": [
                        "定增",
                        "股东大会",
                        "否决",
                        "海欣医药"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}